The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia-Reference-Cited by-同舟云学术

The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia

Published:2021-09-08 Issue:10 Volume:35 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Wu Liting¹,Fan Yingchao¹,Wang Yuan¹,Li Zhumeng¹,Mao Delong²,Zhuang Wenfang¹^ORCID

Affiliation:

1. Medical Laboratory Shidong Hospital, Shidong Hospital Affiliated to University of Shanghai for Science and Technology Yangpu District, ShanghaiChina

2. School of Medical Instrument and Food Engineering University of Shanghai for Science and Technology Shanghai China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.23949

Reference27 articles.

1. Recent insights into the pathogenesis of hyperuricaemia and gout

2. The effect of angiotensin II receptor blockers on hyperuricemia

3. Development of Nephrolithiasis in Asymptomatic Hyperuricemia: A Cohort Study

4. Human renal urate transpoter URAT1 mediates the transport of salicylate;Ohtsu N;Nihon Jinzo Gakkai Shi,2010

5. Physiology of Hyperuricemia and Urate-Lowering Treatments

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study;Drug Metabolism and Personalized Therapy;2022-12-29

2. Altered Serum Uric Acid Levels in Kidney Disorders;Life;2022-11-15

3. The Impact of Hyperuricemia on Patients With Low Body Mass Index After Endovascular Treatments: Data From the I-PAD Registry;Angiology;2022-01-25